Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Potentially Faulty Xarelto Study Data Hid By J&J, Bayer: Report March 7, 2016 Irvin Jackson Add Your Comments According to documents produced during the discovery process in lawsuits filed over the side effects of Xarelto, reports suggest that a major medical journal was misled about the existence of data that may have made it clear whether controversial clinical trial results were accurate. A recent New York Times report indicates that Bayer, Johnson & Johnson and those who ran clinical trials at Duke University that eventually led to the FDA approval of the blood thinner, may have lied to editors at the New England Journal of Medicine. At issue is a device that measured the levels of blood thinner in patients involved in the study, due to concerns that the device was defective and that those running the clinical trial knew it, but failed to reveal that information. Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The New York Times reports that documents produced by the drug makers during pending Xarelto lawsuits filed on behalf of individuals who suffered severe bleeding complications after receiving the drug suggest that those running the clinical trial were asked if there were lab tests that confirmed the accuracy of the device. The editors were told there was not, when in actuality there were such tests. The issue is part of an investigation into the Xarelto studies underway by the FDA, which is focusing on the measurement of the levels of the older blood thinner warfarin in test subjects’ blood. It is now believed that the device was defective and may have compromised the approval process for Xarelto, which has since been promoted as a superior alternative to warfarin. The Xarelto blood testing problems in the clinical trial were first reported in the medical journal The BMJ in December, with researchers warning that the device may have led to an underestimation of the rate of Xarelto bleeding complications in comparison to warfarin. The ROCKET-AF clinical trials compared the rate of bleeding events between Xarelto (rivaroxaban) and Coumadin (warfarin). The potentially defective blood testing device, known as the INRatio by Alere, was used to measure the levels of warfarin in patients’ blood and was used to adjust their dosage. However, an INRatio recall has since been issued after it was discovered that the device may return results that were falsely low. The recall came after Alere received nearly 19,000 reports of malfunctions, 14 of which resulted in serious injuries. The recall could affect the ROCKET-AF results, because falsely low readings may have resulted in warfarin patients being given too high a dose, increasing their risk of bleeding. If the device caused excessive bleeding among warfarin patients, it could have given the false impression that Xarelto had a lower rate of bleeding problems. Researchers reportedly said that the best way to evaluate whether the device was working properly would be a comparison of the device’s readings with tests conducted at a central laboratory. That happened twice in the clinical trials, involving samples from 5,000 patients given warfarin at 12 weeks and 24 weeks in the clinical trial. Editors with the New England Journal of Medicine indicate that they were never shown or told about the results, even though the Xarelto clinical trial researchers were asked directly about it by a peer reviewer. The clinical trials, led by Dr. Robert Califf, who is now the FDA commissioner, have come under intense criticism for a variety of reasons since Xarelto was approved, as the drug has been linked to a surprising number of adverse event reports involving severe and uncontrollable bleeding problems. Due to a lack of a reversal agent for Xarelto, doctors have often been unable to stop bleeding problems that occur among users of the drug, increasing the risk of severe injury or death. Xarelto Lawsuits Over Bleeding Problems Xarelto (rivaroxaban) is part of a new class of blood thinners introduced in recent years as a replacement for warfarin, which had been the go-to anticoagulation treatment for decades. Since it was approved in 2011, this new-generation treatment has been commonly prescribed instead of warfarin for reduction of the risk of blood clots and strokes among patients with atrial fibrillation, or following hip or knee replacement surgery. Amid allegations that the drug makers failed to adequately warn about the risk of bleeding on Xarelto, more than 4,000 lawsuits are currently pending in courts throughout the U.S., alleging that plaintiffs suffered severe and often fatal injuries due to uncontrollable bleeding while on the medication. While users of warfarin can be given a dose of vitamin K to reduce the blood thinning effects of the medication, there were no similar reversal agents available for Xarelto at the time it was introduced, placing doctors in a position where they were unable to control many bleeding problems. Lawsuits also allege that the drug makers provided false and misleading information about the importance of blood monitoring on Xarelto, marketing the drug as easier to use and indicating that it does not require close testing like warfarin. However, independent studies published after the medication was introduced have suggested that Xarelto monitoring may help identify patients at greater risk of bleeds. As part of the coordinated proceedings in the federal Xarelto litigation, a small group of “bellwether” cases are being prepared for early trial dates, which are expected to begin early next year to help gauge how juries may respond to certain evidence that has been obtained during the discovery process. While the outcome of these early bellwether trials will not be binding in other cases, they may facilitate Xarelto settlement negotiations that will avoid the need for hundreds of individual cases to go to trial nationwide. Tags: Bayer, Bleeding, Blood Thinner, Johnson & Johnson, Warfarin, Xarelto More Xarelto Lawsuit Stories Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024 Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022 Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (Posted: today) Lawyers involved in the federal hair relaxer lawsuits submitted a status report in advance of an MDL status conference tomorrow, highlighting a number of ongoing disputes over Defendant Fact Sheets and a potential Science Day. MORE ABOUT: HAIR RELAXER LAWSUITMore Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025) Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (Posted: yesterday) A Florida woman’s Depo-Provera lawsuit indicates she developed hearing loss and tinnitus due to the birth control injection not being adequately tested. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Use for Endometriosis Caused Stroke-Like Symptoms, Golf Ball-Sized Brain Tumor: Lawsuit (04/15/2025)Depo-Provera Lawsuit Case Management Conferences Scheduled Throughout 2025 (04/08/2025)Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (04/01/2025) Nurse Assist Lawsuit Alleges Infection Caused by Saline Solution Used To Clean Wounds (Posted: 2 days ago) A lawsuit filed over recalled Nurse Assist sterile water and saline products indicates the lack of sterility led to infections in leg wounds they were supposed to cleanse. MORE ABOUT: STERILE SALINE SOLUTION RECALL LAWSUITMcKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection (03/21/2025)SteriCare Sodium Chloride Lawsuit Claims Recalled Saline Solution Caused Infection, Wrongful Death (11/12/2024)Nurse Assist Sterile Water and Saline Recalled Following FDA “Do Not Use” Warning (11/07/2023)
Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021
Hair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (Posted: today) Lawyers involved in the federal hair relaxer lawsuits submitted a status report in advance of an MDL status conference tomorrow, highlighting a number of ongoing disputes over Defendant Fact Sheets and a potential Science Day. MORE ABOUT: HAIR RELAXER LAWSUITMore Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)
Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (Posted: yesterday) A Florida woman’s Depo-Provera lawsuit indicates she developed hearing loss and tinnitus due to the birth control injection not being adequately tested. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Use for Endometriosis Caused Stroke-Like Symptoms, Golf Ball-Sized Brain Tumor: Lawsuit (04/15/2025)Depo-Provera Lawsuit Case Management Conferences Scheduled Throughout 2025 (04/08/2025)Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (04/01/2025)
Nurse Assist Lawsuit Alleges Infection Caused by Saline Solution Used To Clean Wounds (Posted: 2 days ago) A lawsuit filed over recalled Nurse Assist sterile water and saline products indicates the lack of sterility led to infections in leg wounds they were supposed to cleanse. MORE ABOUT: STERILE SALINE SOLUTION RECALL LAWSUITMcKesson Sterile Water Lawsuit Filed Against Amazon, Nurse Assist Over Bacterial Wound Infection (03/21/2025)SteriCare Sodium Chloride Lawsuit Claims Recalled Saline Solution Caused Infection, Wrongful Death (11/12/2024)Nurse Assist Sterile Water and Saline Recalled Following FDA “Do Not Use” Warning (11/07/2023)